QQQ   390.19 (+0.26%)
AAPL   190.40 (+0.32%)
MSFT   382.70 (+1.08%)
META   338.99 (+1.28%)
GOOGL   137.20 (+0.58%)
AMZN   147.03 (-0.47%)
TSLA   246.72 (+4.51%)
NVDA   478.21 (-0.87%)
NIO   7.21 (+0.28%)
BABA   76.72 (-1.04%)
AMD   122.01 (-0.52%)
T   16.18 (-0.19%)
F   10.39 (+0.48%)
MU   76.12 (-1.79%)
CGC   0.54 (-1.82%)
GE   118.85 (-0.93%)
DIS   92.50 (-2.81%)
AMC   6.70 (-1.47%)
PFE   29.69 (-1.49%)
PYPL   58.47 (+3.69%)
XOM   103.90 (-0.06%)
QQQ   390.19 (+0.26%)
AAPL   190.40 (+0.32%)
MSFT   382.70 (+1.08%)
META   338.99 (+1.28%)
GOOGL   137.20 (+0.58%)
AMZN   147.03 (-0.47%)
TSLA   246.72 (+4.51%)
NVDA   478.21 (-0.87%)
NIO   7.21 (+0.28%)
BABA   76.72 (-1.04%)
AMD   122.01 (-0.52%)
T   16.18 (-0.19%)
F   10.39 (+0.48%)
MU   76.12 (-1.79%)
CGC   0.54 (-1.82%)
GE   118.85 (-0.93%)
DIS   92.50 (-2.81%)
AMC   6.70 (-1.47%)
PFE   29.69 (-1.49%)
PYPL   58.47 (+3.69%)
XOM   103.90 (-0.06%)
QQQ   390.19 (+0.26%)
AAPL   190.40 (+0.32%)
MSFT   382.70 (+1.08%)
META   338.99 (+1.28%)
GOOGL   137.20 (+0.58%)
AMZN   147.03 (-0.47%)
TSLA   246.72 (+4.51%)
NVDA   478.21 (-0.87%)
NIO   7.21 (+0.28%)
BABA   76.72 (-1.04%)
AMD   122.01 (-0.52%)
T   16.18 (-0.19%)
F   10.39 (+0.48%)
MU   76.12 (-1.79%)
CGC   0.54 (-1.82%)
GE   118.85 (-0.93%)
DIS   92.50 (-2.81%)
AMC   6.70 (-1.47%)
PFE   29.69 (-1.49%)
PYPL   58.47 (+3.69%)
XOM   103.90 (-0.06%)
QQQ   390.19 (+0.26%)
AAPL   190.40 (+0.32%)
MSFT   382.70 (+1.08%)
META   338.99 (+1.28%)
GOOGL   137.20 (+0.58%)
AMZN   147.03 (-0.47%)
TSLA   246.72 (+4.51%)
NVDA   478.21 (-0.87%)
NIO   7.21 (+0.28%)
BABA   76.72 (-1.04%)
AMD   122.01 (-0.52%)
T   16.18 (-0.19%)
F   10.39 (+0.48%)
MU   76.12 (-1.79%)
CGC   0.54 (-1.82%)
GE   118.85 (-0.93%)
DIS   92.50 (-2.81%)
AMC   6.70 (-1.47%)
PFE   29.69 (-1.49%)
PYPL   58.47 (+3.69%)
XOM   103.90 (-0.06%)

Boston Scientific Stock Price, News & Analysis (NYSE:BSX)

$54.93
-0.76 (-1.36%)
(As of 11/28/2023 ET)
Compare
Today's Range
$54.91
▼
$55.74
50-Day Range
$48.64
▼
$55.69
52-Week Range
$43.84
▼
$55.83
Volume
6.45 million shs
Average Volume
8.09 million shs
Market Capitalization
$80.47 billion
P/E Ratio
66.99
Dividend Yield
N/A
Price Target
$60.55
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Boston Scientific MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
10.2% Upside
$60.55 Price Target
Short Interest
Healthy
0.81% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.02
Upright™ Environmental Score
News Sentiment
1.13mentions of Boston Scientific in the last 14 days
Based on 11 Articles This Week
Insider Trading
Selling Shares
$20.79 M Sold Last Quarter
Proj. Earnings Growth
10.95%
From $2.01 to $2.23 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.75 out of 5 stars

Medical Sector

72nd out of 949 stocks

Surgical & Medical Instruments Industry

15th out of 95 stocks

See Top Rated MarketRank™ Stocks Here

BSX stock logo

About Boston Scientific Stock (NYSE:BSX)

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

BSX Stock Price History

BSX Stock News Headlines

November 28, 2023 | theglobeandmail.com
Will Boston Scientific Corporation (BSX) Continue Further upside?
November 28, 2023 | americanbankingnews.com
Boston Scientific (NYSE:BSX) Given New $64.00 Price Target at Canaccord Genuity Group
November 28, 2023 | RYSE INC. (Ad)
Secure your stake in the Smart Home industry.
Last chance to invest in RYSE – the shade automation technology launching in over 100 Best Buy stores this month.
November 27, 2023 | finance.yahoo.com
Boston Scientific Costa Rica Facility Awarded Gender Equality Seal
November 24, 2023 | americanbankingnews.com
Boston Scientific (NYSE:BSX) Hits New 12-Month High at $55.83
November 17, 2023 | markets.businessinsider.com
Boston Scientific Closes Acquisition Of Relievant Medsystems
November 17, 2023 | finance.yahoo.com
Boston Scientific Closes Acquisition of Relievant Medsystems, Inc.
November 17, 2023 | finance.yahoo.com
Insider Sell: EVP Wendy Carruthers Sells 11,671 Shares of Boston Scientific Corp (BSX)
November 28, 2023 | RYSE INC. (Ad)
Secure your stake in the Smart Home industry.
Last chance to invest in RYSE – the shade automation technology launching in over 100 Best Buy stores this month.
November 15, 2023 | benzinga.com
Revolutionizing Breakthroughs in Cardiac Diagnosis and Treatment: Boston Scientific Corporation (NYSE: BSX) vs Catheter Precision (NYSEAMERICAN: VTAK)
November 14, 2023 | bizjournals.com
Boston Scientific's Maple Grove biotech campus plan gets $6M in Minnesota aid
November 14, 2023 | finance.yahoo.com
Boston Scientific (BSX) Just Reclaimed the 50-Day Moving Average
November 8, 2023 | forbes.com
What’s Next For Boston Scientific Stock After 5% Gains In A Week?
November 7, 2023 | finance.yahoo.com
Boston Scientific Corporation (NYSE:BSX) Is Going Strong But Fundamentals Appear To Be Mixed : Is There A Clear Direction For The Stock?
November 3, 2023 | msn.com
Boston College vs. Syracuse odds, spread: 2023 college football picks, Week 10 predictions by proven model
November 3, 2023 | finance.yahoo.com
Possible Bearish Signals With Boston Scientific Insiders Disposing Stock
November 2, 2023 | apnews.com
A man killed a woman, left her body in a car, then boarded a flight to Kenya from Boston, police say
November 2, 2023 | msn.com
Boston police arrest 2 in connection with Princess Charles’ death in September
November 2, 2023 | msn.com
The secret to Boston's success so far? Per Jrue Holiday, 'you stay humble'
November 2, 2023 | msn.com
Indiana Pacers blown out by Boston Celtics for first road loss of 2023-24 season
November 2, 2023 | msn.com
Boston Celtics' superb start continues with most lopsided victory since 1959
November 1, 2023 | msn.com
Chicago-area sex offender charged with traveling to Boston area to abuse minor
November 1, 2023 | msn.com
Watch Live 10:15 AM: Boston Mayor Michelle Wu to provide update on Mass and Cass tent removal
November 1, 2023 | finance.yahoo.com
Boston Scientific to Participate in Stifel's 2023 Healthcare Conference
October 31, 2023 | news.yahoo.com
Department of Labor investigating Boston Market after workers claim they haven’t been paid
October 31, 2023 | msn.com
Judge to determine course of child abuse case against DCYF, New Boston police
October 31, 2023 | markets.businessinsider.com
Neutral Outlook on Boston Scientific Amid Strong Q3 Performance and Uncertain 2024 Factors
See More Headlines
Receive BSX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Boston Scientific and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/26/2023
Today
11/28/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/07/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NYSE:BSX
CUSIP
10113710
CIK
885725
Web
www.bostonscientific.com
Phone
(508) 683-4000
Fax
508-683-5675
Employees
45,000
Year Founded
1979

Price Target and Rating

Average Stock Price Target
$60.55
High Stock Price Target
$66.00
Low Stock Price Target
$55.00
Potential Upside/Downside
+10.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
16 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$0.82
Trailing P/E Ratio
66.99
Forward P/E Ratio
27.33
P/E Growth
2.21
Net Income
$698 million
Net Margins
8.93%
Pretax Margin
13.63%
Return on Equity
15.46%
Return on Assets
8.52%

Debt

Debt-to-Equity Ratio
0.44
Current Ratio
1.42
Quick Ratio
0.90

Sales & Book Value

Annual Sales
$12.68 billion
Price / Sales
6.35
Cash Flow
$2.57 per share
Price / Cash Flow
21.38
Book Value
$12.27 per share
Price / Book
4.48

Miscellaneous

Outstanding Shares
1,464,980,000
Free Float
1,457,219,000
Market Cap
$80.47 billion
Optionable
Optionable
Beta
0.77

Social Links

(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report














BSX Stock Analysis - Frequently Asked Questions

Should I buy or sell Boston Scientific stock right now?

16 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Boston Scientific in the last year. There are currently 1 hold rating, 14 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BSX shares.
View BSX analyst ratings or view top-rated stocks.

What is Boston Scientific's stock price target for 2024?

16 Wall Street research analysts have issued 1-year price targets for Boston Scientific's stock. Their BSX share price targets range from $55.00 to $66.00. On average, they anticipate the company's stock price to reach $60.55 in the next year. This suggests a possible upside of 10.2% from the stock's current price.
View analysts price targets for BSX or view top-rated stocks among Wall Street analysts.

How have BSX shares performed in 2023?

Boston Scientific's stock was trading at $46.27 at the beginning of 2023. Since then, BSX stock has increased by 18.7% and is now trading at $54.93.
View the best growth stocks for 2023 here.

Are investors shorting Boston Scientific?

Boston Scientific saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 11,850,000 shares, an increase of 29.6% from the October 31st total of 9,140,000 shares. Based on an average daily volume of 8,450,000 shares, the short-interest ratio is presently 1.4 days.
View Boston Scientific's Short Interest.

When is Boston Scientific's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 7th 2024.
View our BSX earnings forecast.

How were Boston Scientific's earnings last quarter?

Boston Scientific Co. (NYSE:BSX) posted its quarterly earnings data on Thursday, October, 26th. The medical equipment provider reported $0.50 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.48 by $0.02. The medical equipment provider had revenue of $3.53 billion for the quarter, compared to analyst estimates of $3.48 billion. Boston Scientific had a net margin of 8.93% and a trailing twelve-month return on equity of 15.46%. Boston Scientific's quarterly revenue was up 11.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.43 EPS.
Read the conference call transcript.

What ETFs hold Boston Scientific's stock?

ETFs with the largest weight of Boston Scientific (NYSE:BSX) stock in their portfolio include Fidelity Disruptive Medicine ETF (FMED), Simplify Health Care ETF (PINK), Goldman Sachs Future Health Care Equity ETF (GDOC), iShares U.S. Medical Devices ETF (IHI), Global X Aging Population ETF (AGNG), BlackRock Future Health ETF (BMED), BNY Mellon Sustainable US Equity ETF (BKUS) and JPMorgan Social Advancement ETF (UPWD).

What guidance has Boston Scientific issued on next quarter's earnings?

Boston Scientific updated its fourth quarter earnings guidance on Thursday, October, 26th. The company provided EPS guidance of $0.49-0.52 for the period, compared to the consensus earnings per share estimate of $0.52.

What is Michael F. Mahoney's approval rating as Boston Scientific's CEO?

947 employees have rated Boston Scientific Chief Executive Officer Michael F. Mahoney on Glassdoor.com. Michael F. Mahoney has an approval rating of 98% among the company's employees. This puts Michael F. Mahoney in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Boston Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Boston Scientific investors own include NVIDIA (NVDA), Alibaba Group (BABA), Intel (INTC), AT&T (T), CVS Health (CVS), Walt Disney (DIS), Bank of America (BAC), Advanced Micro Devices (AMD), Visa (V) and Salesforce (CRM).

Who are Boston Scientific's major shareholders?

Boston Scientific's stock is owned by many different institutional and retail investors. Top institutional investors include FMR LLC (8.60%), Massachusetts Financial Services Co. MA (4.27%), Primecap Management Co. CA (2.55%), Morgan Stanley (1.45%), Artisan Partners Limited Partnership (1.22%) and Bank of New York Mellon Corp (1.18%). Insiders that own company stock include Arthur C Butcher, Charles J Dockendorff, Daniel J Brennan, David A Pierce, David A Pierce, David S Wichmann, Edward F Mackey, Eric Francis Yves Thepaut, Ian T Meredith, Jeffrey B Mirviss, Jeffrey B Mirviss, Jodi Euerle Eddy, John Bradley Sorenson, Jonathan Monson, Joseph Michael Fitzgerald, Maulik Nanavaty, Meghan Scanlon, Michael F Mahoney, Michael F Mahoney, Nelda J Connors, Scott Olson, Vance R Brown, Wendy Carruthers and William F Bruss.
View institutional ownership trends.

How do I buy shares of Boston Scientific?

Shares of BSX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

Does Boston Scientific have any subsidiaries?
The following companies are subsidiares of Boston Scientific: 34 Biomedical Merger Corp., 9357-1867 Quebec Inc., Acurate Industria e Comercio Ltda., Advanced Bionics, Advanced Stent Technologies, American Medical Systems, American Medical Systems Europe B.V., Apama Medical, Apama Medical Inc., Asthmatx, Atritech, Augmenix, Augmenix Inc., Augmenix K.K., BSC International Medical Trading (Shanghai) Co. Ltd., BSC Medical Device Technology (Shanghai) Co. Ltd., BTG, BTG Australasia Pty Ltd, BTG Europe B.V., BTG IM Holdings Ltd., BTG International (Holdings) Limited, BTG International Asia Limited, BTG International Canada Inc., BTG International Germany GmbH, BTG International Healthcare Inc., BTG International Healthcare LLC, BTG International Healthcare Limited, BTG International Inc., BTG International Limited, BTG Limited, BTG Management Services Limited, BTG Medikal Limited Sirketi, Bard Electrophysiology, Barosense, Biocompatibles Inc., Biocompatibles International Limited, Biocompatibles UK Limited, Boston Scientific (Malaysia) Sdn. Bhd., Boston Scientific (South Africa) Proprietary Limited, Boston Scientific (Thailand) Ltd., Boston Scientific (UK) Limited, Boston Scientific AG, Boston Scientific Argentina S.A., Boston Scientific Asia Pacific Pte. Ltd., Boston Scientific Benelux NV, Boston Scientific Canada Limited, Boston Scientific Ceska republika s.r.o., Boston Scientific Chile SpA, Boston Scientific Colombia Limitada, Boston Scientific Comercial de Costa Rica BSCR S.R.L., Boston Scientific Far East B.V., Boston Scientific Gesellschaft m.b.H., Boston Scientific Group plc, Boston Scientific Hellas S.A., Boston Scientific Hong Kong Limited, Boston Scientific Iberica S.A., Boston Scientific India Private Limited, Boston Scientific International B.V., Boston Scientific International Finance Limited, Boston Scientific International S.A., Boston Scientific Israel Ltd., Boston Scientific Japan K.K., Boston Scientific Korea Co. Ltd., Boston Scientific Lebanon SAL, Boston Scientific Limited, Boston Scientific Ltd., Boston Scientific Medical Device, Boston Scientific Medical Device Limited, Boston Scientific Medizintechnik GmbH, Boston Scientific Middle East FZ-LLC, Boston Scientific Middle East SAL, Boston Scientific Nederland B.V., Boston Scientific Neuromodulation Corporation, Boston Scientific New Zealand Limited, Boston Scientific Nordic AB, Boston Scientific Peru S.A.C., Boston Scientific Philippines Inc., Boston Scientific Polska Sp. z o.o., Boston Scientific Portugal - Dispositivos Medicos Lda, Boston Scientific Pty Ltd, Boston Scientific Romania S.R.L., Boston Scientific S.A.S., Boston Scientific S.p.A., Boston Scientific Scimed, Boston Scientific Scimed Inc., Boston Scientific Services Private Limited, Boston Scientific TIP Gerecleri Limited Sirketi, Boston Scientific Technology & Engineering Services Private Limited, Boston Scientific Uruguay S.A., Boston Scientific Vietnam Company Limited, Boston Scientific de Costa Rica S.R.L., Boston Scientific de Mexico S.A. de C.V., Boston Scientific del Caribe Inc., Boston Scientific do Brasil Ltda., Bravo Bidco Limited, BridgePoint Medical, Cameron Health, Cardiac Pacemakers Inc., Cardiac Pathways Corp, Catheter Innovations, Claret Medical, Claret Medical Inc., Cosman Medical, Cosman Medical LLC, CryoCor, Cryterion Medical, Cryterion Medical Inc., Cryterion Medical Ireland Limited, EKOS LLC, EMcision, EMcision International Inc., EP Technologies, EP Technologies Inc., Electron Acquisition Corporation, EndoChoice, EndoChoice Holdings Inc., EndoChoice Inc., EndoChoice Innovation Center Ltd., EndoChoice Israel Ltd., Endotex, Enteric Medical Technologies, Galil Medical Inc., Galil Medical Ltd., Galil Medical UK Limited, Guidant, Guidant Delaware Holding Corporation, Guidant Europe NV, Guidant Puerto Rico B.V., Hong Kong Medtech Trading Limited, Intelect Medical, Millipede, Millipede Inc., NXT Merger Corp., Notebook Merger Sub Ltd., Novate Medical Limited, NxThera, NxThera Inc., PT Boston Scientific Indonesia, PneumRx GmbH, PneumRx LLC, PneumRx Liimited, Protherics Medicines Development B.V., Protherics Medicines Development Limited, Protherics UK Limited, Provensis Limited, RMI Acquisition Corp., Remon Medical Technologies, Rhythmia Medical, Robert S. Smith M.D. Inc., Roxwood Medical Inc., SNS Merger Corp, Sadra Medical, Sadra Medical Inc., Securus Medical Group, Securus Medical Group Inc., Special K Merger Corp., StarMedTec, Stream Enterprises LLC, Symetis, Symetis SA, Target Therapeutics, Target Therapeutics Inc., The LumenR Tissue Retractor System, Veniti, Veniti Inc., VertiFlex, Vertiflex Inc., Vessix Vascular, Xlumena, Zuma Investment Pty Ltd, iogyn, nVision Medical, and nVision Medical Corporation.
Read More
This page (NYSE:BSX) was last updated on 11/28/2023 by MarketBeat.com Staff

My Account -